SCHEMBL1710381

SCHEMBL1710381

O=Cc1cn(CCCCl)c(=O)c2ccc(Br)cc12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.37
NPC1 O15118 2/20 0.37
MAPT P10636 2/20 0.37
RAB9A P51151 2/20 0.37
LMNA P02545 2/20 0.37
HPGD P15428 2/20 0.37
HTT P42858 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
PTPN1 P18031 1/20 0.36
CYP2A6 P11509 2/20 0.35
PIM1 P11309 1/20 0.35
PIM3 Q86V86 1/20 0.35
KRAS P01116 1/20 0.35
POLB P06746 1/20 0.34
MCL1 Q07820 1/20 0.33
ABCC2 Q92887 1/20 0.33
ERN1 O75460 1/20 0.33
PTGDR2 Q9Y5Y4 1/20 0.33
PTGS2 P35354 1/20 0.33
NPSR1 Q6W5P4 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6648077 0.84 NPC1 (0.47) ALDH1A1NPC1MAPTRAB9ALMNA
SCHEMBL1710413 0.80 ALDH1A1 (0.49) ALDH1A1NPC1MAPTRAB9ALMNA
SCHEMBL1710361 0.79 KRAS (0.35) ALDH1A1LMNAPTPN1CYP2A6PIM1
SCHEMBL2423167 0.76 MAPK8 (0.39) MAPTPTPN1CYP2A6PIM1PIM3
SCHEMBL27775821 0.75 ALDH1A1 (0.38) ALDH1A1MAPTLMNAHTTSMN1; SMN2
SCHEMBL2420795 0.74 ALDH1A1 (0.48) ALDH1A1NPC1MAPTRAB9AHTT
SCHEMBL1710390 0.73 KRAS (0.35) LMNASMN1; SMN2PTPN1CYP2A6PIM1
SCHEMBL2419435 0.73 MAPK8 (0.46) ALDH1A1MAPTLMNAHTTSMN1; SMN2
SCHEMBL14043617 0.72 ALDH1A1 (0.38) ALDH1A1MAPTLMNAHTTSMN1; SMN2
SCHEMBL1725380 0.72 TNF (0.39) ALDH1A1NPC1RAB9AHPGDPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102245593-A Isoquinolinone derivatives ASTRAZENECA AB 2011-11-16 CN disclosed
US-8012980-B2 Isoquinolinone derivatives ASTRAZENECA AB (SE) 2011-09-06 US disclosed
EP-2344472-A1 ISOQUINOLINONE DERIVATIVES AstraZeneca AB (SE) 2011-07-20 EP disclosed
US-20100099665-A1 ISOQUINOLINONE DERIVATIVES ASTRAZENECA AB (SE) 2010-04-22 US disclosed
WO-2010039079-A1 ISOQUINOLINONE DERIVATIVES ASTRAZENECA AB (SE) 2010-04-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100099665-A1 ISOQUINOLINONE DERIVATIVES SDHA, NQO1, CYP3A5 ALDH1A1 121/4885NPC1 254/4885MAPT 955/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.